Article
Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors.
Japanese journal of cancer research : Gann - 1 Apr 2002
Okada Yuka, Okada Naoki, Nakagawa Shinsaku, Mizuguchi Hiroyuki, Takahashi Koichi, Mizuno Nobuyasu, Fujita Takuya, Yamamoto Akira, Hayakawa Takao, Mayumi Tadanori
Abstract excerpt
Although adenovirus vectors (Ad) provide high-level transduction efficacy to many cell types, extremely high doses of Ad are required for sufficient gene transduction into several tumors, including melanoma. Here, we demonstrated that the expression of coxsackie-adenovirus receptor, a primitive Ad-receptor, was very low in murine and human melanoma cells. We also found that fiber-mutant Ad containing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
